Hangzhou Zhongtai Cryogenic Technology Corporation(300435.SZ)
No price history available.
Key financial summary
Financials in CNY| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | CNYm | 1,978 | 2,407 | 3,256 | 3,047 | 2,717 | 2,751 | 2,595 | 2,940 |
| Operating profit | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | CNYm | 196 | 245 | 278 | 350 | -78 | 450 | 393 | 547 |
| EPS reported | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in CNY| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Hangzhou Zhongtai Cryogenic Technology Corporation (HTCTC), established in 2006 and based in Hangzhou, China, is a specialist in the development, design, manufacturing, and sale of advanced cryogenic equipment. The company's extensive product range includes sophisticated packaged units such as: Cryogenic liquefaction plants for liquefied natural gas (LNG) production. Cryogenic purification plants specifically designed for liquid nitrogen washing applications. Cryogenic separation plants used in H2-CO separation processes. HTCTC also excels in producing various cold box products, catering to diverse industrial needs including LNG, liquid nitrogen washing, ethylene production, air separation units (ASU), propane dehydrogenation (PDH) propylene, methanol-to-olefins/propylene (MTO/MTP) conversions, and carbon monoxide management. Furthermore, their offerings extend to high-performance plate-fin heat exchangers, notably aluminum plate-fin heat exchangers and specialized ethylene column overhead condensers/plate-fin vessels. Serving a broad spectrum of critical industries, HTCTC's clientele spans the energy, chemical, metallurgy, electric power generation, liquefied natural gas, and modern coal chemical sectors. While primarily focused on the domestic Chinese market, the company also maintains an international presence, exporting its solutions to countries like the United States, various European nations, and India.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Hangzhou Zhongtai Cryogenic Technology Corporation (300435.SZ)
No price history available.
Based on consensus from external analysts. Not Kvantra's opinion.
Hangzhou Zhongtai Cryogenic Technology Corporation (HTCTC), established in 2006 and based in Hangzhou, China, is a specialist in the development, design, manufacturing, and sale of advanced cryogenic equipment. The company's extensive product range includes sophisticated packaged units such as: Cryogenic liquefaction plants for liquefied natural gas (LNG) production. Cryogenic purification plants specifically designed for liquid nitrogen washing applications. Cryogenic separation plants used in H2-CO separation processes. HTCTC also excels in producing various cold box products, catering to diverse industrial needs including LNG, liquid nitrogen washing, ethylene production, air separation units (ASU), propane dehydrogenation (PDH) propylene, methanol-to-olefins/propylene (MTO/MTP) conversions, and carbon monoxide management. Furthermore, their offerings extend to high-performance plate-fin heat exchangers, notably aluminum plate-fin heat exchangers and specialized ethylene column overhead condensers/plate-fin vessels. Serving a broad spectrum of critical industries, HTCTC's clientele spans the energy, chemical, metallurgy, electric power generation, liquefied natural gas, and modern coal chemical sectors. While primarily focused on the domestic Chinese market, the company also maintains an international presence, exporting its solutions to countries like the United States, various European nations, and India.
